Regorafenib

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

RegoNivo vs Standard of Care Chemotherapy in AGOC

Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.

Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment

Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy

Regorafenib in Patients With Refractory Primary Bone Tumors

Phase II Study of Regorafenib as Maintenance Therapy

Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting

Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer

A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib